Longterm Followup of Patients With Rheumatoid Arthritis Treated With Methotrexate
NCT02641977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 271
Last updated 2018-10-19
Summary
Longterm followup of patients with rheumatoid arthritis 30 years after starting a baseline treatment with Methotrexate.
Conditions
- External Causes of Morbidity and Mortality
Sponsors & Collaborators
-
Ruhr University of Bochum
lead OTHER
Principal Investigators
-
Dietmar MJ Krause, MD · University Bochum, Germany
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-08-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-08-31
Countries
- Germany
Study Locations
More Related Trials
-
An Observational Study on the Safety and Effectiveness of Rituximab in Patients With Severe Active Rheumatoid Arthritis
NCT01071798 ·Status: COMPLETED
-
Comparison of Combination Disease Modifying Antirheumatic Drugs With Methotrexate Therapy in Early Rheumatoid Arthritis
NCT02644499 ·Status: COMPLETED ·Phase: PHASE4
-
An Observational Study on Patients With Rheumatoid Arthritis Treated With MabThera (Rituximab)
NCT01075477 ·Status: COMPLETED
-
Impact of Rituximab on MRI Evidence of Disease Activity in Patients With Moderate to Severe Rheumatoid Arthritis
NCT00425932 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Safety and Efficacy of Rituximab in Patients With Moderate to Severe Rheumatoid Arthritis Receiving Methotrexate
NCT00243412 ·Status: COMPLETED ·Phase: PHASE2
-
A Study on Rheumatoid Arthritis Patients Treated With Rituximab
NCT02622503 ·Status: COMPLETED
-
Treatment of TNFa Naive Patients With Poor Prognosis Rheumatoid Arthritis
NCT00963703 ·Status: COMPLETED ·Phase: NA
-
Association Between Methotrexate Erythrocyte Polyglutamate Concentration and Clinical Response in Rheumatoid Arthritis Patients Treated With Subcutaneous Injectable Methotrexate
NCT03445871 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate Compared to Methotrexate Alone in Patients With Active Rheumatoid Arthritis
NCT00299130 ·Status: COMPLETED ·Phase: PHASE3
-
Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis
NCT00847886 ·Status: COMPLETED ·Phase: PHASE1
-
The Effect of Adalimumab Plus Methotrexate (MTX) Versus Placebo Plus MTX on Cartilage in (RA) Patients
NCT02150473 ·Status: TERMINATED ·Phase: PHASE3
-
Study of the Safety of MDX-1342 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
NCT00639834 ·Status: COMPLETED ·Phase: PHASE1
-
Methotrexate (Rheumatrex) High Dose Special Investigation (Regulatory Post Marketing Commitment Plan)
NCT01414257 ·Status: COMPLETED
-
Methotrexate Polyglutamate Levels as a Marker for the Clinical Outcome in the Treatment of Rheumatoid Arthritis
NCT00695188 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy
NCT00844714 ·Status: COMPLETED ·Phase: NA
-
A Study of Retreatment With MabThera (Rituximab) in Combination With Methotrexate in Patients With Rheumatoid Arthritis (RA)
NCT00422383 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Assess the Efficacy and Safety of Repeat Treatment With Rituximab (MabThera) in Participants With Active Rheumatoid Arthritis (RA)
NCT02093026 ·Status: COMPLETED ·Phase: PHASE2
-
Observational Study of Rituxan in Rheumatoid Arthritis Patients in Routine Clinical Practice
NCT00984711 ·Status: UNKNOWN
-
A Pharmacokinetic and Pharmacodynamic Study of MabThera (Rituximab) Plus Methotrexate in Patients With Rheumatoid Arthritis (RA)
NCT00422942 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of GSK3196165 Plus Methotrexate in Subjects With Active Moderate-Severe Rheumatoid Arthritis
NCT02504671 ·Status: COMPLETED ·Phase: PHASE2
-
Paroxetine Safety and Efficacy in Rheumatoid Arthritis
NCT06231745 ·Status: COMPLETED ·Phase: PHASE3
-
U-Act-After: An Observational Study on Long-Term Efficacy of Tight Control RoActemra/Actemra (Tocilizumab) and/or Methotrexate in Patients With Early Rheumatoid Arthritis Who Have Participated in the U-Act-Early Study (ML22497)
NCT01918267 ·Status: COMPLETED
-
The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment
NCT02837978 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
NCT04571697 ·Status: COMPLETED
-
ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)
NCT05279417 ·Status: COMPLETED ·Phase: PHASE2